After several months of hard work, we have finalised the first phase of our trials! During this phase we have been able to validate our new LAMP assay with 183 samples and show 90.5% sensitivity and 100% specificity with detection in under 20 minutes. We have also incorporated the assay on our platform and demonstrated average detection of 12.9 min with 40 samples.
Our publication is available online: https://www.medrxiv.org/content/10.1101/2020.06.29.20142349v1 .
We are excited to announce that Phase 2 will start imminently as we will be heading to Charing Cross Hospital to validate our new test from sample to result. Stay tuned for more!